<DOC>
	<DOCNO>NCT01164592</DOCNO>
	<brief_summary>The purpose study ass change leave ventricular performance use echocardiography well ventricular remodelling , change sleep change mood , anxiety cognitive function occur result treatment predominant central sleep apnoea adaptive servoventilation ( ASV ) chronic heart failure addition optimal medical therapy chronic heart failure . This substudy SERVE-HF study .</brief_summary>
	<brief_title>Substudy Mechanistic Plausibility Clinical Benefits Adaptive Servo-ventilation</brief_title>
	<detailed_description>This substudy perform within SERVE-HF Study , randomise , multi-centre , international trial parallel group design , patient randomise either control ( optimal medical management ) active treatment ( optimal medical treatment plus use adaptive servoventilation ) 1:1 ratio . The randomization parent study . For purpose , randomization parent study stratify whether patient include substudy . 300 patient recruit substudy overall . For purpose substudy , patient follow period 12 month . The following extra test perform baseline visit , 3 month follow 12 month follow : - Echocardiogram ( group ) - cMRI ( group ) - PSG ( baseline visit patient treatment group 3 month follow 12 month follow patient ) - 4 questionnaire ( group ) - Additional blood testing ( group )</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Cheyne-Stokes Respiration</mesh_term>
	<criteria>The inclusion exclusion criterion mainly applicable parent study ; SERVE−HF . The inclusion exclusion criterion list . INCLUSION CRITERIA FOR SERVEHF STUDY : Over 22 year age Severe Chronic Heart Failure ( CHF ) NYHA class III−IV NYHA class II least one hospitalisation HF within last 24 month Left ventricular ejection fraction ( LVEF ) less equal 45 % mean echocardiography , radionucleotide angiography , leave ventriculography cardiac MRI document less 12 week randomisation Diagnosis sleep disorder breathing ( SDB ) apnoea−hypopnoea−index ( AHI ) &gt; 15/hr least 50 % central event central AHI least 10/hr Clinically stable change medication unplanned hospitalisation heart failure precede month Optimised medical treatment accord applicable guideline Able provide inform consent ADDITIONAL INCLUSION CRITERIA FOR THE SUBSTUDY • Predominant central sleep apnoea ( apnoea hypopnoea index &gt; 15/hour ≥ 50 % central event central AHI ≥10/hour , derive full polysomnography ( base total sleep time ) , document less 4 week randomization . Flow measurement perform nasal cannula EXCLUSION CRITERIA FOR THE SERVEHF STUDY : Significant chronic obstructive pulmonary disease ( COPD ) Forced Expiratory Volume within one second ( FEV1 ) &lt; 50 % predict Oxygen saturation rest day 90 % time inclusion Current use Positive Airway Pressure ( PAP ) therapy Life expectancy &lt; 1 year disease unrelated chronic heart failure Cardiac surgery , Percutaneous coronary intervention ( PCI ) , Myocardial Infarction ( MI ) unstable angina within 6 month prior randomisation Implantation ICD ( implanted cardiodefibrillator ) CRT ( cardiac resynchronisation therapy ) schedule within 6 month prior randomisation Transient ischemic attack ( TIA ) Stroke within 3 month prior randomisation Primary hemodynamically significant uncorrected valvular heart disease , obstructive regurgitant , valvular disease expect lead surgery trial Acute myocarditis/pericarditis within 6 month prior randomisation Untreated therapy refractory Restless legs Syndrome ( RLS ) Pregnancy ADDITIONAL EXCLUSION CRITERIA FOR THE SUBSTUDY Amyloidosis , hypertrophic obstructive cardiomyopathy arteriovenous fistula Dosage change diuretic double within last 4 week prior randomisation</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Heart failure ( HF )</keyword>
	<keyword>Sleep disorder breathing ( SDB )</keyword>
	<keyword>Cheyne Stokes Respiration ( CSR )</keyword>
	<keyword>Adaptive Servoventilation ( ASV )</keyword>
</DOC>